FOXO3 and colorectal carcinoma: Yu Y. and colleagues demonstrated that FoxO3a, a transcriptional factor with an important regulatory function in the CRC cell survival, confers cetuximab resistance in RAS mutated colorectal cancer cell lines through a c-MYC induced expression [26].